← Back to headlines
Truist Maintains Buy Rating for Insulet Corporation (PODD) Despite Device Correction
Truist has reiterated its "Buy" rating for Insulet Corporation (PODD), even after the company announced a device correction.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
